Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

46.84 +4.61 (+10.90%)
Streaming Delayed Price Updated: 2:04 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Twist Bioscience Stock Scores Relative Strength Rating Upgrade
When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84. 
Via Investor's Business Daily
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
From Twist Bioscience Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More
This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
What Are the Risks With Twist Bioscience?
One especially stands out. 
Via The Motley Fool
Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
TWST earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Why Does Cathie Wood Like This Healthcare Stock So Much?
Twist Bioscience brings to mind another genomic revolution pioneer. 
Via The Motley Fool
3 Exciting Biotech Stocks to Buy Right Now
Gene therapies could be poised to enter an era of extraordinarily rapid advancement. 
Via The Motley Fool
Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
From Twist Bioscience Corporation
Via Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
From Twist Bioscience Corporation
Via Business Wire
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities
From Twist Bioscience Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021
Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago... 
Via Benzinga
Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software
From Twist Bioscience
Via Business Wire
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg... 
Via Benzinga
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.